Roan Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Roan Capital Partners's BMY Position: Q2 2026 in Review
Roan Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 5% in Q2 2026, buying an estimated $12.5K and bringing the position to 4,589 shares worth $264K. The position accounts for 0.22% of the portfolio, ranked #65.
Roan Capital Partners first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $265K in Q1 2026. 2,502 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Roan Capital Partners held 4,589 shares of Bristol-Myers Squibb worth $264K as of Q2 2026.
- Roan Capital Partners bought 218 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.5K.
- Bristol-Myers Squibb made up 0.22% of Roan Capital Partners's portfolio in Q2 2026, its #65 holding.
- Roan Capital Partners first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Roan Capital Partners's Bristol-Myers Squibb position peaked at $265K in Q1 2026.
- 2,502 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Roan Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.